4//SEC Filing
Mathew Aby J. 4
Accession 0001628280-24-052104
CIK 0000834365other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 5:19 PM ET
Size
7.4 KB
Accession
0001628280-24-052104
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-12-16$27.33/sh−7,604$207,817→ 276,315 total - Sale
Common Stock
2024-12-17$27.16/sh−13,196$358,403→ 263,119 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 6-14-2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.88 to $28.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.62 to $27.48, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001556355
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 5:19 PM ET
- Size
- 7.4 KB